Cargando…
Chronic Enterovirus Meningoencephalitis in Prolonged B-Cell Depletion After Rituximab Therapy: Case Report
OBJECTIVES: Persistent impaired immunity is possible even years after B-cell depleting therapies. This may favor the occurrence of infections, including infectious meningitis and encephalitis. In this study, we report a case of chronic enterovirus meningoencephalitis in prolonged B-cell depletion ye...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10574820/ https://www.ncbi.nlm.nih.gov/pubmed/37813597 http://dx.doi.org/10.1212/NXI.0000000000200171 |
_version_ | 1785120779075059712 |
---|---|
author | Jacksch, Clemens Dargvainiene, Justina Böttcher, Sindy Diedrich, Sabine Leypoldt, Frank Stürner, Klarissa Berg, Daniela Schäffer, Eva |
author_facet | Jacksch, Clemens Dargvainiene, Justina Böttcher, Sindy Diedrich, Sabine Leypoldt, Frank Stürner, Klarissa Berg, Daniela Schäffer, Eva |
author_sort | Jacksch, Clemens |
collection | PubMed |
description | OBJECTIVES: Persistent impaired immunity is possible even years after B-cell depleting therapies. This may favor the occurrence of infections, including infectious meningitis and encephalitis. In this study, we report a case of chronic enterovirus meningoencephalitis in prolonged B-cell depletion years after rituximab therapy. METHODS: This is a case report from a German academic hospital. In addition to repeated clinical examinations, repeated brain MRI and extended CSF and laboratory diagnostics were performed. We used the CARE checklist when writing our report. RESULTS: A 38-year-old man presented with high fever (>40°C), severe headache, and progressive neurologic and cognitive deficits. As result of previous lymphoma therapy with rituximab years ago, prolonged B-cell aplasia was detected. To restore humoral immunity, the patient received repeated infusions of immunoglobulins. In the end, a complete restitution of the physical and mental condition was achieved with the established therapy. DISCUSSION: This case report should emphasize the importance of assessing humoral immunity even years after B-cell depletion therapy, especially in case of opportunistic infections. |
format | Online Article Text |
id | pubmed-10574820 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-105748202023-10-14 Chronic Enterovirus Meningoencephalitis in Prolonged B-Cell Depletion After Rituximab Therapy: Case Report Jacksch, Clemens Dargvainiene, Justina Böttcher, Sindy Diedrich, Sabine Leypoldt, Frank Stürner, Klarissa Berg, Daniela Schäffer, Eva Neurol Neuroimmunol Neuroinflamm Research Article OBJECTIVES: Persistent impaired immunity is possible even years after B-cell depleting therapies. This may favor the occurrence of infections, including infectious meningitis and encephalitis. In this study, we report a case of chronic enterovirus meningoencephalitis in prolonged B-cell depletion years after rituximab therapy. METHODS: This is a case report from a German academic hospital. In addition to repeated clinical examinations, repeated brain MRI and extended CSF and laboratory diagnostics were performed. We used the CARE checklist when writing our report. RESULTS: A 38-year-old man presented with high fever (>40°C), severe headache, and progressive neurologic and cognitive deficits. As result of previous lymphoma therapy with rituximab years ago, prolonged B-cell aplasia was detected. To restore humoral immunity, the patient received repeated infusions of immunoglobulins. In the end, a complete restitution of the physical and mental condition was achieved with the established therapy. DISCUSSION: This case report should emphasize the importance of assessing humoral immunity even years after B-cell depletion therapy, especially in case of opportunistic infections. Lippincott Williams & Wilkins 2023-10-09 /pmc/articles/PMC10574820/ /pubmed/37813597 http://dx.doi.org/10.1212/NXI.0000000000200171 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Research Article Jacksch, Clemens Dargvainiene, Justina Böttcher, Sindy Diedrich, Sabine Leypoldt, Frank Stürner, Klarissa Berg, Daniela Schäffer, Eva Chronic Enterovirus Meningoencephalitis in Prolonged B-Cell Depletion After Rituximab Therapy: Case Report |
title | Chronic Enterovirus Meningoencephalitis in Prolonged B-Cell Depletion After Rituximab Therapy: Case Report |
title_full | Chronic Enterovirus Meningoencephalitis in Prolonged B-Cell Depletion After Rituximab Therapy: Case Report |
title_fullStr | Chronic Enterovirus Meningoencephalitis in Prolonged B-Cell Depletion After Rituximab Therapy: Case Report |
title_full_unstemmed | Chronic Enterovirus Meningoencephalitis in Prolonged B-Cell Depletion After Rituximab Therapy: Case Report |
title_short | Chronic Enterovirus Meningoencephalitis in Prolonged B-Cell Depletion After Rituximab Therapy: Case Report |
title_sort | chronic enterovirus meningoencephalitis in prolonged b-cell depletion after rituximab therapy: case report |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10574820/ https://www.ncbi.nlm.nih.gov/pubmed/37813597 http://dx.doi.org/10.1212/NXI.0000000000200171 |
work_keys_str_mv | AT jackschclemens chronicenterovirusmeningoencephalitisinprolongedbcelldepletionafterrituximabtherapycasereport AT dargvainienejustina chronicenterovirusmeningoencephalitisinprolongedbcelldepletionafterrituximabtherapycasereport AT bottchersindy chronicenterovirusmeningoencephalitisinprolongedbcelldepletionafterrituximabtherapycasereport AT diedrichsabine chronicenterovirusmeningoencephalitisinprolongedbcelldepletionafterrituximabtherapycasereport AT leypoldtfrank chronicenterovirusmeningoencephalitisinprolongedbcelldepletionafterrituximabtherapycasereport AT sturnerklarissa chronicenterovirusmeningoencephalitisinprolongedbcelldepletionafterrituximabtherapycasereport AT bergdaniela chronicenterovirusmeningoencephalitisinprolongedbcelldepletionafterrituximabtherapycasereport AT schaffereva chronicenterovirusmeningoencephalitisinprolongedbcelldepletionafterrituximabtherapycasereport |